A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma
Abstract The limited performance of guideline‐recommended abdominal ultrasound and serum alpha‐fetoprotein (AFP) highlights the urgent, unmet need for new biomarkers for more accurate detection of early hepatocellular carcinoma (HCC). To this end, we have conducted a prospective clinical validation...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-07-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1918 |